TEXT-S&P summary: Sanofi

Sanofi's key business strengths include its critical mass in research and
development (R&D) and marketing, which we view as key success factors for the
pharmaceutical industry. This has enabled it to build up a substantial drug
development pipeline, which includes 18 new molecular entities and vaccines in
late-stage development. This compares well with international peers, in our
view. The ratings are also supported by our view of the group's exposure to
highly diversified and sizabl

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/6_IwKTBF2SA/idUSWLB030220120524

ladder shelf stackable chairs custom rubber stamp